Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FF/Vilanterol versus fluticasone propionate/salmeterol in persistent asthma
2010-019589-10Phase 3Completed
- Sponsor
- GSK
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent asthma and asthma comparing Fluticasone furoate + vilanterol with Fluticasone propionate + salmeterol (2 arms). Primary endpoint: Weighted mean 24-hour serial FEV1. Started May 2010; status: completed.
02
Drugs
fluticasonevilanterolfluticasone propionatesalmeterol
03
Conditions
persistent asthmaasthma
Beyond the preview
Go deeper on 2010-019589-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019589-10.